Page last updated: 2024-09-03

etomoxir and Mitochondrial Myopathies

etomoxir has been researched along with Mitochondrial Myopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acquaviva, C; Benoist, JF; Chevalier, S; Dumas, JF; Gouache, E; Labarthe, F; Lefort, B; Servais, S; Tardieu, M; Vianey-Saban, C	1

Other Studies

1 other study(ies) available for etomoxir and Mitochondrial Myopathies

Article	Year
Pharmacological inhibition of carnitine palmitoyltransferase 1 restores mitochondrial oxidative phosphorylation in human trifunctional protein deficient fibroblasts. Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:6 Topics: Cardiomyopathies; Carnitine O-Palmitoyltransferase; Epoxy Compounds; Female; Fibroblasts; Humans; Infant; Infant, Newborn; Lipid Metabolism, Inborn Errors; Male; Mitochondria; Mitochondrial Myopathies; Mitochondrial Trifunctional Protein; Nervous System Diseases; Oxidative Phosphorylation; Rhabdomyolysis	2017

Article

Year

Pharmacological inhibition of carnitine palmitoyltransferase 1 restores mitochondrial oxidative phosphorylation in human trifunctional protein deficient fibroblasts.

Biochimica et biophysica acta. Molecular basis of disease, 2017, Volume: 1863, Issue:6

Topics: Cardiomyopathies; Carnitine O-Palmitoyltransferase; Epoxy Compounds; Female; Fibroblasts; Humans; Infant; Infant, Newborn; Lipid Metabolism, Inborn Errors; Male; Mitochondria; Mitochondrial Myopathies; Mitochondrial Trifunctional Protein; Nervous System Diseases; Oxidative Phosphorylation; Rhabdomyolysis

2017